Global Gamma Knife Market, By Disease Indications (Vascular Disorders, Brain Metastasis, Ocular Diseases, Functional Disorders, Arteriovenous Malformation (AVM), Trigeminal Neuralgia, Movement Disorders, Cancer and Others), Anatomy (Head, Neck and Others), End User (Hospitals, Clinics and Ambulatory Service Centres) - Industry Trends and Forecast to 2030.
Gamma Knife Market Analysis and Size
The gamma knife market is rising steadily as a result of the increasing incidence of neurological disorders. Growing R & D activities is considerably driving the Global Gamma Knife Market. Strategic initiatives by the key market players are one of the elements driving the market's rapid rise. Market players are expanding their product offerings in order to acquire a competitive advantage. [AN1]
Data Bridge Market Research analyses that the global gamma knife market which was USD 424.70 Million in 2022, will reach USD 627.48 Million by 2030, and is expected to undergo a CAGR of 5.0% during the forecast period. “Vascular disorders” dominates the disease indiations segment of the Global Gamma Knife Market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Gamma Knife Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015-2020) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered |
Disease Indications (Vascular Disorders, Brain Metastasis, Ocular Diseases, Functional Disorders, Arteriovenous Malformation (AVM), Trigeminal Neuralgia, Movement Disorders, Cancer and Others), Anatomy (Head, Neck and Others), End User (Hospitals, Clinics and Ambulatory Service Centres), |
Countries Covered |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa |
Market Players Covered |
Elekta AB (Sweden), Varian Medical Systems, Inc. (U.S.), Accuray Incorporated (U.S.), GENERAL ELECTRIC COMPANY(U.S.), Koninklijke Philips N.V.(Netherlands), American Radiosurgery Inc.(U.S.), Hitachi, Ltd.(Japan), American Shared Hospital Services (U.S.), MASEP(South Korea), CyberMed Health Inc.(U.S.), Nordion (Canada) Inc. (Canada), UT Health East Texas.(U.S.), Blount Memorial Hospital (U.S.), Brainlab (Germany), BondWellOrtho (India), Ono Sokki India Private Limited. (India), Panacea Medical Technologies Pvt. Ltd. (India), and Panacea Medical Technologies Pvt. Ltd.(India) |
Market Opportunities |
|
Market Definition
The global Gamma Knife market refers to the worldwide market for Gamma Knife radiosurgery systems and related products and services.The Gamma Knife is a non-invasive surgical technology used in the treatment of various neurological conditions, primarily brain tumors and other brain disorders. It utilizes highly focused radiation beams to precisely target and treat specific areas of the brain, while minimizing damage to surrounding healthy tissues.
Global Gamma Knife Market Dynamics
Drivers
- Non-invasiveness and minimal side effects
The Gamma Knife procedure is non-invasive and does not require open surgery. It uses highly focused radiation beams to target and treat specific areas of the brain while sparing surrounding healthy tissues. This minimizes the risk of complications and side effects compared to traditional surgical methods, making it an attractive option for patients.
- Awareness and acceptance
There is a growing awareness among patients and healthcare professionals about the benefits of Gamma Knife surgery. As more clinical evidence supports its efficacy and safety, the acceptance and adoption of this technology are increasing globally.
Opportunities
- Technological advancements
Continued advancements in Gamma Knife technology present opportunities for market growth. Manufacturers can focus on improving imaging capabilities, treatment planning software, and radiation delivery systems to enhance precision, efficiency, and patient outcomes. Developing more compact and versatile systems could also expand the applicability of Gamma Knife technology.
Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, rising number of market players will further expand the market's growth rate in the future.
Restraints/Challenges
On the other hand, the high cost associated with the product manufacturing is expected to obstruct market growth. Also, the disruption in the supply chain industry has the potential to challenge the market’s growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, and lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.
This Gamma Knife Market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Gamma Knife Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- Brainlab, a digital medical technology company, announced the acquisition of Mint Medical GmbH, a medical technology company proficient in manufacturing image reading and reporting software for clinical routine and research. This acquisition will foster growth in the automation of radiology reports through AI anatomical mapping and formulation of holistic data.
Global Gamma Knife Market Scope
The Gamma Knife Market is segmented on the basis of disease indications, anatomy, and end user. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Disease Indications
- Vascular Disorders
- Brain Metastasis
- Ocular Diseases
- Functional Disorders
- Arteriovenous Malformation (AVM)
- Trigeminal Neuralgia
- Movement Disorders
- Cancer
- Others
Anatomy
- Head
- Neck
- Others
End User
- Hospitals
- Clinics
- Ambulatory Service Centers
Global Gamma Knife Market Regional Analysis/Insights
The Gamma Knife Market is analyzed, and market size insights and trends are provided by disease indications, anatomy and end user as referenced above.
The countries covered in the Gamma Knife Market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.
North America dominates the market due to factors including rising healthcare costs, increased R&D related to diabetes management and trending technological advancements.
Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 because of the rising strategic initiatives by the key market players and favourable government initiatives in the region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The Gamma Knife market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Gamma Knife market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Gamma Knife market. The data is available for historic period 2015-2021.
Competitive Landscape and Gamma Knife Market Share Analysis
The Gamma Knife market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Gamma Knife market.
Some of the major players operating in the Gamma Knife market are:
- Elekta AB (Sweden)
- Varian Medical Systems, Inc.(U.S.)
- Accuray Incorporated (U.S.)
- GENERAL ELECTRIC COMPANY(U.S.)
- Koninklijke Philips N.V.(Netherlands)
- American Radiosurgery Inc.(U.S.)
- Hitachi, Ltd.(Japan)
- American Shared Hospital Services (U.S.)
- MASEP(South Korea)
- CyberMed Health Inc.(U.S.)
- Nordion (Canada) Inc. (Canada)
- UT Health East Texas.(U.S.)
- Blount Memorial Hospital (U.S.)
- Brainlab (Germany)
- BondWellOrtho (India)
- Ono Sokki India Private Limited. (India)
- Panacea Medical Technologies Pvt. Ltd.(India)
SKU-